Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Kathy Gately

Clinical Senior Lecturer

Trinity College Dublin

Ireland

Research Interests

Explore related searches

Professors in Ireland Professors in Cell Biology Cell Biology professors in Ireland

About

Dr. Kathy Gately is a Clinical Senior Lecturer at Trinity College Dublin, Ireland. Her research focuses on the biological and clinical challenges of tumor cells in various cancers, including pleural mesothelioma and non-small cell lung cancer. Recent publications include studies on the prevalence of CD276 expression in mesothelioma, circulating tumor cell technologies, and treatment strategies for KRAS-mutated lung cancer.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (13)

Lucy Norris

Senior Research Fellow /Principal Investigator

Trinity College Dublin Faculty of Health Sciences

IRELAND

View details

sharon o toole

Trinity College Dublin

IRELAND

View details

Robert Smyth

Assistant Professor

University of Iowa Hospitals and Clinics

UNITED STATES

View details

Darran O'Connor

Professor

Royal College of Surgeons in Ireland

IRELAND

View details

Paul J. Buchanan

IRELAND

View details

Alex Eustace

Assistant Professor in Biotechnology

Dublin City University

IRELAND

View details

Sinead Toomey

Royal College of Surgeons in Ireland

IRELAND

View details

John Crown

St. Vincent's University Hospital

IRELAND

View details

Denis Collins

Assistant Professor / PI Cancer Biotherapeutics Research Group

Dublin City University

IRELAND

View details

Carmen Blanco-Aparicio

Head of Biology Section

Centro Nacional de Investigaciones Oncológicas

SPAIN

View details

Doug Brooks

Professor

University of South Australia

AUSTRALIA

View details

Stephen Finn

Associate Professor

Trinity College Dublin School of Medicine

IRELAND

View details

Emanuela Felley‐Bosco

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kathy Gately

Research Interests

Explore related searches

About

Articles (16)

Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape Project

Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination

A pilot study evaluating the feasibility of enriching and detecting circulating tumour cells from peripheral and ovarian veins in rare epithelial ovarian carcinomas

Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)

Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer

European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.

Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC

Vaping and lung cancer - A review of current data and recommendations.

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.

Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.

Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer

PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer

Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer

Collaborators (13)

Lucy Norris

sharon o toole

Robert Smyth

Darran O'Connor

Paul J. Buchanan

Alex Eustace

Sinead Toomey

John Crown

Denis Collins

Carmen Blanco-Aparicio

Doug Brooks

Stephen Finn

Emanuela Felley‐Bosco

Make your next move.